Maria Trojanowska, PhD

Professor, Medicine

Maria Trojanowska
617.638.4318
75 E. Newton St Evans Building

Other Positions

  • Director, Arthritis Center, Boston University School of Medicine

Education

  • Polish Academy of Sciences, PhD
  • University of Warsaw, MSc

Publications

  • Published on 2/7/2018

    Saigusa R, Asano Y, Taniguchi T, Hirabayashi M, Nakamura K, Miura S, Yamashita T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Trojanowska M, Sato S. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells. Arthritis Res Ther. 2018 Feb 07; 20(1):23. PMID: 29415756.

    Read at: PubMed
  • Published on 11/15/2017

    Stawski L, Marden G, Trojanowska M. The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway. J Immunol. 2018 Jan 01; 200(1):248-259. PMID: 29141862.

    Read at: PubMed
  • Published on 9/1/2017

    Toyama T, Looney AP, Baker BM, Stawski L, Haines P, Simms R, Szymaniak AD, Varelas X, Trojanowska M. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis. J Invest Dermatol. 2018 Jan; 138(1):78-88. PMID: 28870693.

    Read at: PubMed
  • Published on 7/1/2017

    Looney AP, Han R, Stawski L, Marden G, Iwamoto M, Trojanowska M. Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis. Am J Respir Cell Mol Biol. 2017 Jul; 57(1):121-131. PMID: 28248553.

    Read at: PubMed
  • Published on 6/13/2017

    Makino K, Makino T, Stawski L, Lipson KE, Leask A, Trojanowska M. Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis. Arthritis Res Ther. 2017 Jun 13; 19(1):134. PMID: 28610597.

    Read at: PubMed
  • Published on 4/19/2017

    Makino K, Makino T, Stawski L, Mantero JC, Lafyatis R, Simms R, Trojanowska M. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis. J Invest Dermatol. 2017 Aug; 137(8):1671-1681. PMID: 28433542.

    Read at: PubMed
  • Published on 2/28/2017

    Farina A, Peruzzi G, Lacconi V, Lenna S, Quarta S, Rosato E, Vestri AR, York M, Dreyfus DH, Faggioni A, Morrone S, Trojanowska M, Farina GA. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Arthritis Res Ther. 2017 Feb 28; 19(1):39. PMID: 28245863.

    Read at: PubMed
  • Published on 2/23/2017

    Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, Ichimura Y, Toyama T, Taniguchi T, Akamata K, Noda S, Yoshizaki A, Tsuruta D, Trojanowska M, Sato S. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma. J Exp Med. 2017 Apr 03; 214(4):1129-1151. PMID: 28232470.

    Read at: PubMed
  • Published on 2/2/2017

    Grzegorzewska AP, Seta F, Han R, Czajka CA, Makino K, Stawski L, Isenberg JS, Browning JL, Trojanowska M. Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways. Sci Rep. 2017 Feb 02; 7:41605. PMID: 28150703.

    Read at: PubMed
  • Published on 10/21/2016

    Yamashita T, Asano Y, Taniguchi T, Nakamura K, Saigusa R, Miura S, Toyama T, Takahashi T, Ichimura Y, Yoshizaki A, Trojanowska M, Sato S. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis. J Invest Dermatol. 2017 Mar; 137(3):631-640. PMID: 27777101.

    Read at: PubMed

View 126 more publications: View full profile at BUMC

View all profiles